Literature DB >> 14745647

Prolonged effect of botulinum toxin injection in the treatment of cricopharyngeal dysphagia: case report and literature review.

Ming-Jang Chiu1, Yeun-Chung Chang, Tzu-Yu Hsiao.   

Abstract

Cricopharyngeus (CP) muscle spasm can lead to severe dysphagia. Myotomy of the CP muscle was the treatment of choice. Recently, botulinum toxin type A (BtxA) has been used for CP spasm. It usually brings improvement in deglutition but most patients require reinjection in 3-5 months. We report a 35-year-old man who had an arteriovenous malformation hemorrhage in the brain stem resulting in CP spasm and consequently severe dysphagia. He received BtxA injection and deglutition and nutrition remained good one year after treatment. A literature review analyzing 28 patients and our patient showed negative correlations between age and BtxA dose and between age and duration. Efficacy was positively correlated with duration and BtxA dose was positively correlated with pretreatment severity. In conclusion, physicians would use higher doses on patients with more severe cases but use lower doses on older patients. Those who obtained better post-treatment results would enjoy longer effective duration. Thus, the effective duration of the BtxA is multifactorial.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745647     DOI: 10.1007/s00455-003-0029-3

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  25 in total

1.  Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease.

Authors:  Domenico A Restivo; Agostino Palmeri; Rosario Marchese-Ragona
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Cricopharyngeal dysfunction in Parkinson's disease: role in dysphagia and response to myotomy.

Authors:  L J Born; R H Harned; L F Rikkers; R F Pfeiffer; E M Quigley
Journal:  Mov Disord       Date:  1996-01       Impact factor: 10.338

3.  Botulinum toxin in hypertensive lower esophageal sphincter.

Authors:  M P Jones
Journal:  Am J Gastroenterol       Date:  1996-06       Impact factor: 10.864

4.  Changes in the electron microscopic structure of slow and fast skeletal muscle fibres of the mouse after the local injection of botulinum toxin.

Authors:  L W Duchen
Journal:  J Neurol Sci       Date:  1971-09       Impact factor: 3.181

5.  Dose standardisation of botulinum toxin.

Authors:  M H Marion; M Sheehy; S Sangla; S Soulayrol
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

6.  Endoscopic botulinum toxin injection for cricopharyngeal dysphagia.

Authors:  Mahesh S Parameswaran; Ahmed M S Soliman
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-10       Impact factor: 1.547

7.  Mechanisms of action of phenol block and botulinus toxin Type A in relieving spasticity: electrophysiologic investigation and follow-up.

Authors:  A Y On; Y Kirazli; B Kismali; R Aksit
Journal:  Am J Phys Med Rehabil       Date:  1999 Jul-Aug       Impact factor: 2.159

8.  Swallowing disorders in muscular diseases: functional assessment and indications of cricopharyngeal myotomy.

Authors:  J L St Guily; S Périé; T N Willig; S Chaussade; B Eymard; B Angelard
Journal:  Ear Nose Throat J       Date:  1994-01       Impact factor: 1.697

9.  Botulinum toxin injection of the cricopharyngeus muscle for the treatment of dysphagia.

Authors:  S F Ahsan; R J Meleca; J P Dworkin
Journal:  Otolaryngol Head Neck Surg       Date:  2000-05       Impact factor: 5.591

10.  Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia.

Authors:  A Blitzer; M F Brin
Journal:  Otolaryngol Head Neck Surg       Date:  1997-03       Impact factor: 5.591

View more
  6 in total

1.  Speech pathologist practice patterns for evaluation and management of suspected cricopharyngeal dysfunction.

Authors:  Corinne A Jones; Molly A Knigge; Timothy M McCulloch
Journal:  Dysphagia       Date:  2014-02-06       Impact factor: 3.438

2.  Gastrointestinal Uses of Botulinum Toxin.

Authors:  Maria Cariati; Maria Michela Chiarello; Marco Cannistra'; Maria Antonietta Lerose; Giuseppe Brisinda
Journal:  Handb Exp Pharmacol       Date:  2021

Review 3.  Botulinum toxin for gastrointestinal disorders: therapy and mechanisms.

Authors:  H Vittal; P F Pasricha
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

4.  Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future?

Authors:  Brian E Lacy; Kirsten Weiser; Abigail Kennedy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-04

Review 5.  Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction.

Authors:  Pengxu Wei
Journal:  Toxins (Basel)       Date:  2022-04-30       Impact factor: 5.075

6.  Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction.

Authors:  Elizabeth A Kelly; Ian J Koszewski; Safwan S Jaradeh; Albert L Merati; Joel H Blumin; Jonathan M Bock
Journal:  Ann Otol Rhinol Laryngol       Date:  2013-02       Impact factor: 1.547

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.